Претрага
Резултати
Anticancer effects of sclareol and its derivatives in glioblastoma cells [2021]
Kostić, Ana![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
Molecular mechanisms of nanoparticle-mediated biological effects in doxorubicin treated cells (✓) [2021]
Stankov, Karmen![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
Role of TP53 and PTEN tumor suppressor genes alterations in breast cancer response to therapy (✓) [2021]
Nedeljković, Milica![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
Association between TGFB1 C-509T polymorphism and acute toxicity after radiotherapy for prostate cancer (✓) [2021]
Mališić, Emina![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
NF-κB as common target gene of miRNAs related to oxidative stress and prostate cancer radiotherapy response (✓) [2021]
Petrović, Nina![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
Drug repurposing in pancreatic ductal adenocarcinoma (✓) [2021]
Jelena Grahovac; Jelena Grahovac![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
The effects of Salinomycin on melanoma cell lines of different invasiveness (✓) [2021]
Ristić, Dusica; Markovic, Milan![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
Quality of life in patients surgically treated for oral carcinoma (✓) [2021]
Petrović, Anđelija; Keković, Goran![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
The expression of microRNA-30a-3p and estrogen receptor β in papillary thyroid cancer (✓) [2021]
Todorović, Lidija![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
Inhibition of cancer growth with NF-kB suppressor nitroglycerin can be reversed by NF-kB stimulation in hamster fibrosarcoma (✓) [2021]
Popović, Dušica![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
Филтери
По типу
- 29